Give You and Your Loved Ones the Flu... with FluMist
The FDA approved the 'nasal flu-vaccine' FluMist for self-administration on Friday. Per FDA data, FluMist causes flu symptoms, increases hospitalization rates and can infect others through shedding.
September 24, 2024: FluMist is a nasal flu vaccine that is FDA approved for adults and children as young as 2 years of age. On Friday, September 20, 2024, the FDA approved FluMist for self-administration by adults, meaning you can ‘vaccinate’ yourself and your loved ones at home without the supervision of a medical professional.
Per the FDA submitted data, FluMist causes flu symptoms, significantly increases hospitalization rates (over 6000% in babies), and vaccinated individuals can infect others through shedding.
In other words…